The package of outcome measures originally proposed aimed to measure drug and alcohol consumption, and social, emotional and physical wellbeing.
Health care providers deemed the package of outcome measures originally proposed by health researchers as too lengthy and time consuming to complete.
Our package of outcome measures is based on those we have used successfully in two previous large scale community based trials of LBP treatments and are in line with international recommendations [ 26, 27].
In response to health care providers' feedback, the package of outcome measures was revised to include demographics questions, the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) [ 25], K-5 [ 22], GEM scenarios [ 21], and health care service use questions.
The bothersomeness of low back pain question was recommended as part of the internationally agreed package of outcome measures for primary care back pain studies [ 9] and was anglicised to troublesomeness as one of the outcomes of a large scale RCT of manual therapies for low back pain [ 10].
To address these issues, a package of patient-centered outcome measures was designed that reflected the holistic and individualized nature of IHC care.
However, it is also essential that further well designed clinical trials which utilise both child and parent proxy completed QoL measures are conducted and in particular head-to-head studies of different treatment packages with a broad range of outcomes over extended periods of time, with multiple testing points are required.
Roehrig expressed skepticism about whether this policy would work, noting, "Some continue to hope that the DPRK may yet be willing to relinquish its nuclear weapons for a suitable package of incentives, but that outcome appears increasingly unlikely".
The motivating application area is injury prevention in children where a broad array of outcomes and intervention packages have been evaluated with the aim of increasing safety practices around the home (to ultimately reduce household injuries).
The Department of Health and National Institute for Health and Clinical Excellence (NICE) have developed a comprehensive package of national guidance (the Improving Outcomes Guidance) for different cancers, including rare tumours.
